相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis
R. Harpaz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and Multi-item Gamma Poisson Shrinker
Conny Berlin et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership
Patrick B. Ryan et al.
STATISTICS IN MEDICINE (2012)
A Likelihood Ratio Test Based Method for Signal Detection With Application to FDA's Drug Safety Data
Lan Huang et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2011)
Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership
Paul E. Stang et al.
ANNALS OF INTERNAL MEDICINE (2010)
Validation of Statistical Signal Detection Procedures in EudraVigilance Post-Authorization Data A Retrospective Evaluation of the Potential for Earlier Signalling
Yolanda Alvarez et al.
DRUG SAFETY (2010)
A basic study design for expedited safety signal evaluation based on electronic healthcare data
Sebastian Schneeweiss
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Decision support methods for the detection of adverse events in post-marketing data
M. Hauben et al.
DRUG DISCOVERY TODAY (2009)
An Evaluation of Three Signal-Detection Algorithms Using a Highly Inclusive Reference Event Database
Alan M. Hochberg et al.
DRUG SAFETY (2009)
The New Sentinel Network - Improving the Evidence of Medical-Product Safety
Richard Platt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Quantitative signal detection using spontaneous ADR reporting
A. Bate et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
Gianluca Trifiro et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Antipsychotics, Glycemic Disorders, and Life-Threatening Diabetic Events: A Bayesian Data-Mining Analysis of the FDA Adverse Event Reporting System (1968-2004)
William Dumouchel et al.
ANNALS OF CLINICAL PSYCHIATRY (2008)
Impact of Stratification on Adverse Drug Reaction Surveillance
Johan Hopstadius et al.
DRUG SAFETY (2008)
An evaluation of computer-aided disproportionality analysis for post-marketing signal detection
H. P. Lehman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Novel statistical tools for monitoring the safety of marketed drugs
J. S. Almenoff et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Data mining for signals in spontaneous reporting databases: proceed with caution
Wendy P. Stephenson et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Statin safety: An appraisal from the adverse event reporting system
MH Davidson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
The inconsistency of optimal cutpoints obtained using two criteria based on the receiver operating characteristic curve
NJ Perkins et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Comparative performance of two quantitative safety signalling methods - Implications for use in a pharmacovigilance department
June S. Almenoff et al.
DRUG SAFETY (2006)
Reply: The evaluation of data mining methods for the simultaneous and systematic detection of safety signals in large databases: lessons to be learned
JG Levine et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Diagnostic performance of digital versus film mammography for breast-cancer screening
ED Pisano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Comparing data mining methods on the VAERS database
D Banks et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: A retrospective evaluation
M Hauben et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions
C Bousquet et al.
DRUG SAFETY (2005)
Perspectives on the use of data mining in pharmacovigilance
J Almenoff et al.
DRUG SAFETY (2005)
Comparison of data mining methodologies using Japanese spontaneous reports
K Kubota et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2004)
Replication of the weber effect using postmarketing adverse event reports voluntarily submitted to the United States food and drug administration
NR Hartnell et al.
PHARMACOTHERAPY (2004)
Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA)
BJ Martin et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2004)
Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA)
EG Brown
DRUG SAFETY (2003)
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
EP van Puijenbroek et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the USFDA's spontaneous reports database
A Szarfman et al.
DRUG SAFETY (2002)
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
SJW Evans et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2001)
分享论文
